Amgen Inc.
MX ˙ BMV ˙ NL0000888691
SecurityMX:AMGN / Amgen Inc.
InstitutionJT Stratford LLC
Latest Disclosed Ownership905 shares
Latest Disclosed Value $ 318,424
JT Stratford LLC reports 7.37% decrease in ownership of AMGN / Amgen Inc.

On May 15, 2026 - JT Stratford LLC filed a 13F-HR form disclosing ownership of 905 shares of Amgen Inc. (MX:AMGN) valued at $318,424 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 977 shares of Amgen Inc.. This represents a change in shares of -7.37% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F AMGEN COM 031162100 905 -72 -7.37 318 -0.31 0.0405
2026-02-12 2025-12-31 13F AMGEN COM 031162100 977 -43 -4.22 320 11.15 0.0411
2025-11-12 2025-09-30 13F AMGEN COM 031162100 1,020 -413 -28.82 288 -28.25 0.0385
2025-08-13 2025-06-30 13F AMGEN COM 031162100 1,433 -33 -2.25 400 -12.28 0.0605
2025-05-14 2025-03-31 13F AMGEN COM 031162100 1,466 356 32.07 457 57.79 0.0808
2025-02-18 2024-12-31 13F AMGEN COM 031162100 1,110 -1,223 -52.42 289 -61.52 0.0476
2024-11-14 2024-09-30 13F AMGEN COM 031162100 2,333 143 6.53 752 9.80 0.1285
2024-08-14 2024-06-30 13F AMGEN COM 031162100 2,190 165 8.15 684 18.96 0.1271
2024-05-14 2024-03-31 13F AMGEN COM 031162100 2,025 2,025 576 0.1146
2023-11-14 2023-09-30 13F AMGEN COM 031162100 0 -1,651 -100.00 0 -100.00
2023-08-14 2023-06-30 13F AMGEN COM 031162100 1,651 123 8.05 367 -0.81 0.0987
2023-05-10 2023-03-31 13F AMGEN COM 031162100 1,528 1,528 369 0.1062
2021-11-15 2021-09-30 13F AMGEN COM 031162100 0 -6,262 -100.00 0 -100.00
2021-08-16 2021-06-30 13F AMGEN COM 031162100 6,262 -204 -3.15 1,526 -5.16 0.4881
2021-05-12 2021-03-31 13F AMGEN COM 031162100 6,466 78 1.22 1,609 9.53 0.5671
2021-02-16 2020-12-31 13F AMGEN COM 031162100 6,388 250 4.07 1,469 -5.83 0.5506
2020-11-13 2020-09-30 13F AMGEN COM 031162100 6,138 -3,882 -38.74 1,560 -33.98 0.6725
2020-08-14 2020-06-30 13F AMGEN COM 031162100 10,020 887 9.71 2,363 27.66 1.2165
2020-05-14 2020-03-31 13F AMGEN COM 031162100 9,133 -678 -6.91 1,851 -21.73 1.1336
2020-02-14 2019-12-31 13F AMGEN COM 031162100 9,811 -1,092 -10.02 2,365 12.09 1.0833
2019-11-19 2019-09-30 13F AMGEN COM 031162100 10,903 1,200 12.37 2,110 18.01 1.1869
2019-08-14 2019-06-30 13F AMGEN COM 031162100 9,703 705 7.84 1,788 4.62 0.9918
2019-05-15 2019-03-31 13F AMGEN COM 031162100 8,998 574 6.81 1,709 4.21 0.9813
2019-02-14 2018-12-31 13F AMGEN COM 031162100 8,424 6,622 367.48 1,640 338.50 1.0913
2018-11-14 2018-09-30 13F AMGEN COM 031162100 1,802 52 2.97 374 15.79 0.2145
2018-08-13 2018-06-30 13F AMGEN COM 031162100 1,750 1 0.06 323 8.39 0.1989
2018-05-14 2018-03-31 13F AMGEN COM 031162100 1,749 89 5.36 298 3.11 0.1861
2018-02-15 2017-12-31 13F AMGEN COM 031162100 1,660 -273 -14.12 289 -19.72 0.1886
2017-11-14 2017-09-30 13F AMGEN COM 031162100 1,933 28 1.47 360 9.76 0.2331
2017-08-14 2017-06-30 13F AMGEN COM 031162100 1,905 -50 -2.56 328 2.18 0.2307
2017-05-12 2017-03-31 13F AMGEN COM 031162100 1,955 -13,005 -86.93 321 -85.32 0.2384
2017-02-09 2016-12-31 13F AMGEN COM 031162100 14,960 14,960 2,187 1.8371
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.